venlafaxine

Generic: venlafaxine

Labeler: ajanta pharma usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine
Generic Name venlafaxine
Labeler ajanta pharma usa inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 37.5 mg/1

Manufacturer
Ajanta Pharma USA Inc.

Identifiers & Regulatory

Product NDC 27241-221
Product ID 27241-221_a85661b9-217a-41ca-90d8-d1e29052e44d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214691
Listing Expiration 2026-12-31
Marketing Start 2023-04-12

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 27241221
Hyphenated Format 27241-221

Supplemental Identifiers

RxCUI
808744 808748 808751 808753
UPC
0327241222306 0327241223303 0327241224300 0327241221309
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine (source: ndc)
Generic Name venlafaxine (source: ndc)
Application Number ANDA214691 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 37.5 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-221-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-221-90)
source: ndc

Packages (2)

Ingredients (1)

venlafaxine hydrochloride (37.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a85661b9-217a-41ca-90d8-d1e29052e44d", "openfda": {"upc": ["0327241222306", "0327241223303", "0327241224300", "0327241221309"], "unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748", "808751", "808753"], "spl_set_id": ["22d4817c-1f19-4490-8a38-d8904f0374f7"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-221-30)", "package_ndc": "27241-221-30", "marketing_start_date": "20230412"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-221-90)", "package_ndc": "27241-221-90", "marketing_start_date": "20230412"}], "brand_name": "Venlafaxine", "product_id": "27241-221_a85661b9-217a-41ca-90d8-d1e29052e44d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "27241-221", "generic_name": "Venlafaxine", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Venlafaxine", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "37.5 mg/1"}], "application_number": "ANDA214691", "marketing_category": "ANDA", "marketing_start_date": "20230412", "listing_expiration_date": "20261231"}